BRCA变异对非转移性乳腺癌患者预后的影响
Alper Türkel1, Ilknur Deliktaş Onur1, Hicran Anik1
1Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
Annals of human genetics
|August 29, 2024
概括
患有BRCA1变异的患者患有更具侵略性的乳腺癌,包括三阴性类型,生存率可能更差. 然而,BRCA变异改善了对新辅助疗法的反应,使非转移性乳腺癌患者受益.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- BRCA变异与遗传性乳腺癌有关.
- 了解BRCA在非转移性乳腺癌中的作用对于预后和治疗至关重要.
研究的目的:
- 将非转移性乳腺癌患者的临床病理特征与BRCA变异的患者进行比较.
- 评估BRCA变异对乳腺癌结果的预后影响.
主要方法:
- 追溯分析938名非转移性乳腺癌患者接受BRCA变异检测.
- 分类为三个组:没有BRCA变异,BRCA1变异和BRCA2变异.
主要成果:
- BRCA1变异与更高的Ki67,更高的等级和更多的三阴性乳腺癌相关.
- 与没有BRCA (87.7%) 和BRCA2 (95.3%) 相比,对于BRCA1变异患者 (69.9%) 的5年无疾病生存率明显更差.
- 在BRCA变异患者中,对新辅助疗法的病理完整响应率显著提高 (49.2%对29.6%).
结论:
- 在非转移性乳腺癌中,BRCA1变异表明瘤生物学更具侵略性,潜在的存活率更差.
- 在患有BRCA变异的患者中,新辅助疗法反应得到增强,这表明治疗效益.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.2K
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
13.1K
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
